nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A novel nomogram to predict overall survival in head and neck cancer survivors with radiation-induced brain necrosis
|
Pan, Dong |
|
|
168 |
C |
p. 121-129 |
artikel |
2 |
Assessing toxicities of curative radiotherapy combined with concomitant non anti-cancer drugs: A sub-analysis of the prospective epidemiological RIT trial
|
Magné, Nicolas |
|
|
168 |
C |
p. 23-27 |
artikel |
3 |
Benefit from adjuvant radiotherapy according to the number of risk factors in cutaneous squamous cell carcinoma
|
Pêtre, Adeline |
|
|
168 |
C |
p. 53-60 |
artikel |
4 |
Clinical evaluation of autonomous, unsupervised planning integrated in MR-guided radiotherapy for prostate cancer
|
Künzel, Luise A. |
|
|
168 |
C |
p. 229-233 |
artikel |
5 |
Contents
|
|
|
|
168 |
C |
p. v-vi |
artikel |
6 |
Defining the expected 30-day mortality for patients undergoing palliative radiotherapy: A meta-analysis
|
Kutzko, Justin Henry |
|
|
168 |
C |
p. 147-210 |
artikel |
7 |
Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study
|
Westerveld, Henrike |
|
|
168 |
C |
p. 8-15 |
artikel |
8 |
Editorial Board
|
|
|
|
168 |
C |
p. ii |
artikel |
9 |
Establishment and validation of a recursive partitioning analysis based prognostic model for guiding re-radiotherapy in locally recurrent nasopharyngeal carcinoma patients
|
Sun, Xue-Song |
|
|
168 |
C |
p. 61-68 |
artikel |
10 |
Evaluation of robustly optimised intensity modulated proton therapy for nasopharyngeal carcinoma
|
Scandurra, Daniel |
|
|
168 |
C |
p. 221-228 |
artikel |
11 |
Evaluation of the prognostic value of the ESTRO EORTC classification of oligometastatic disease in patients treated with stereotactic body radiotherapy: A retrospective single center study
|
Willmann, Jonas |
|
|
168 |
C |
p. 256-264 |
artikel |
12 |
Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy
|
Cho, Yeona |
|
|
168 |
C |
p. 1-7 |
artikel |
13 |
Orbital adenoid cystic carcinoma arising from nasopharyngeal salivary gland origin
|
North, Victoria S. |
|
|
168 |
C |
p. 104-105 |
artikel |
14 |
Patient derived ex vivo tissue slice cultures demonstrate a profound DNA double-strand break repair defect in HPV-positive oropharyngeal head and neck cancer
|
Zech, Henrike Barbara |
|
|
168 |
C |
p. 138-146 |
artikel |
15 |
Patterns of disease events and causes of death in patients with HPV-positive versus HPV-negative oropharyngeal carcinoma
|
Gorphe, Philippe |
|
|
168 |
C |
p. 40-45 |
artikel |
16 |
Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG-PET/CT external beam radiation treatment planning in lung cancer
|
Vaz, Sofia C. |
|
|
168 |
C |
p. 37-39 |
artikel |
17 |
Radiotherapy and newly approved cancer drugs – A quantitative analysis of registered protocols for drugs approved for the treatment of solid tumors
|
Rabe, Leonie |
|
|
168 |
C |
p. 69-74 |
artikel |
18 |
Radiotherapy for patients with Ledderhose disease: Long-term effects, side effects and patient-rated outcome
|
de Haan, Anneke |
|
|
168 |
C |
p. 83-88 |
artikel |
19 |
Randomised single centre double-blind placebo controlled phase II trial of Tocovid SupraBio in combination with pentoxifylline in patients suffering long-term gastrointestinal adverse effects of radiotherapy for pelvic cancer: The PPALM study
|
Andreyev, H. Jervoise N. |
|
|
168 |
C |
p. 130-137 |
artikel |
20 |
Recommended first-line management of brain metastases from melanoma: A multicenter survey of clinical practice
|
Jablonska, Paola Anna |
|
|
168 |
C |
p. 89-94 |
artikel |
21 |
SMART ablation of lymphatic oligometastases in the pelvis and abdomen: Clinical and dosimetry outcomes
|
Regnery, Sebastian |
|
|
168 |
C |
p. 106-112 |
artikel |
22 |
Sunitinib with concomitant radiation therapy in inoperable sarcomas: Final results from the dose escalation and expansion parts of a multicenter phase I study
|
Sunyach, Marie-Pierre |
|
|
168 |
C |
p. 95-103 |
artikel |
23 |
Survival benefits for non-small cell lung cancer patients treated with adaptive radiotherapy
|
Møller, Ditte Sloth |
|
|
168 |
C |
p. 234-240 |
artikel |
24 |
The dosimetric and clinical advantages of the GTV-CTV-PTV margins reduction by 6 mm in head and neck squamous cell carcinoma: Significant acute and late toxicity reduction
|
Al-Mamgani, Abrahim |
|
|
168 |
C |
p. 16-22 |
artikel |
25 |
The dosimetric impact of axillary nodes contouring variability in breast cancer radiotherapy: An AIRO multi-institutional study
|
Leonardi, Maria Cristina |
|
|
168 |
C |
p. 113-120 |
artikel |
26 |
The European Particle Therapy Network (EPTN) consensus on the follow-up of adult patients with brain and skull base tumours treated with photon or proton irradiation
|
De Roeck, Laurien |
|
|
168 |
C |
p. 241-249 |
artikel |
27 |
The impact of radiation induced lymphopenia in the prognosis of head and neck cancer: A systematic review and meta-analysis
|
Dai, Dongjun |
|
|
168 |
C |
p. 28-36 |
artikel |
28 |
Tumor response evaluation by combined modalities of chest magnetic resonance imaging and computed tomography in locally advanced non-small cell lung cancer after concurrent chemoradiotherapy
|
Wang, DaQuan |
|
|
168 |
C |
p. 211-220 |
artikel |
29 |
Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer
|
Kerns, Sarah L. |
|
|
168 |
C |
p. 75-82 |
artikel |
30 |
Vital organ sparing with proton therapy for pediatric Hodgkin lymphoma: Toxicity and outcomes in 50 patients
|
Tringale, Kathryn R. |
|
|
168 |
C |
p. 46-52 |
artikel |
31 |
Xerostomia quality of life and resource requirements following parotid sparing adaptive radiotherapy in head and neck cancers: Results of a prospective cohort study (Study ID CTRI/2017/11/010683)
|
Chatterjee, Sanjoy |
|
|
168 |
C |
p. 250-255 |
artikel |